• One-Cycle BE500P Seems Safe for High-Risk Early Testicular Cancer drugs
    January 07, 2020
    For high-risk stage 1 nonseminoma germ cell tumors of the testis (NSGCTT), one cycle of adjuvant bleomycin, etoposide (500 mg/m²), and cisplatin (BE500P) is safe, resulting in a two-year malignant recurrence (MR) rate of 1.3 percent ...
PharmaSources Customer Service